Novo Nordisk raises 2026 outlook on stronger GLP-1 sales
Go back to Novo Nordisk raises 2026 outlook on stronger GLP-1 sales| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.60 | 52 Week High | $59.00 | |||
| Open | $46.60 | 52 Week Low | $32.80 | |||
| Day High | $46.60 | P/E | N/A | |||
| Day Low | $46.60 | EPS | $0.00 | |||
| Volume | 97,093 | |||||

